AbbVie (ABBV) revenue

Revenue · fiscal 2025
$61.16B

AbbVie (ABBV) reported revenue of $61.16B in fiscal 2025 (the year ended December 31, 2025). That is 8.6% higher than the $56.33B of fiscal 2024. Figures as of 19 Nov 2026, 11:14 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Revenue, fiscal 2025
$61.16B
Change on fiscal 2024
+8.6%
Growth, 5 years
+6.0% a year
Growth, 10 years
+10.3% a year
Highest on record
$61.16Bfiscal 2025
Lowest on record
$17.44Bfiscal 2011
Fiscal years on record
152011–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

AbbVie revenue, in more detail

Over the five fiscal years to 2025 revenue grew at a compound 6.0% a year; over ten years the rate was 10.3% a year. Across the 15 fiscal years on record (2011–2025), the highest was $61.16B in fiscal 2025 and the lowest $17.44B in fiscal 2011.

History · 15 fiscal years

Revenue by fiscal year

AbbVie revenue, year by year

AbbVie (ABBV) revenue by fiscal year
Fiscal yearRevenueChangeYear ended
2025$61.16B 8.6% up
2024$56.33B 3.7% up
2023$54.32B 6.4% down
2022$58.05B 3.3% up
2021$56.20B 22.7% up
2020$45.80B 37.7% up
2019$33.27B 1.6% up
2018$32.75B 16.1% up
2017$28.22B 10.1% up
2016$25.64B 12.2% up
2015$22.86B 14.5% up
2014$19.96B 6.2% up
2013$18.79B 2.2% up
2012$18.38B 5.4% up
2011$17.44B—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

How to read it

Steady growth in revenue is the raw material for everything else; a fall means the company is selling less or charging less.

Revenue at health care companies of similar size

Revenue of AbbVie and comparable companies
CompanyRevenueFiscal year
Eli Lilly LLY$65.18B2025
Johnson & Johnson JNJ$94.19B2025
AbbVie ABBV$61.16B2025
Merck & Co MRK$65.01B2025
UnitedHealth Group UNH$447.57B2025
Novartis NVS$56.67B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on ABBV

AbbVie, figure by figure

AbbVie (ABBV) overview: price, valuation and scorecardAll health care companies by market value

AbbVie revenue: questions and answers

What is AbbVie's revenue?

AbbVie (ABBV) reported revenue of $61.16B in fiscal 2025 (the year ended December 31, 2025). That is 8.6% higher than the $56.33B of fiscal 2024.

What is the growth rate of AbbVie's revenue?

Over the five fiscal years to 2025 revenue grew at a compound 6.0% a year; over ten years the rate was 10.3% a year.

What are the highest and lowest revenue figures on record for AbbVie?

Across the 15 fiscal years on record (2011–2025), the highest was $61.16B in fiscal 2025 and the lowest $17.44B in fiscal 2011.

How is AbbVie's revenue calculated?

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement. For AbbVie it is on record here for 15 fiscal years, 2011 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “AbbVie (ABBV) revenue”, data as of 19 November 2026. https://funkfolio.com/stock/ABBV/revenue

Underlying data: the company's filings with the SEC and Yahoo Finance.